Daniel Faga - 21 Mar 2022 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role
Interim CEO, Director
Signature
/s/ Eric Loumeau, Attorney-in-Fact
Issuer symbol
ANAB
Transactions as of
21 Mar 2022
Transactions value $
$0
Form type
4
Filing time
23 Mar 2022, 16:48:01 UTC
Previous filing
14 Feb 2022
Next filing
10 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANAB Common Stock Award $0 +887K $0.00 887K 21 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Certain of the restricted stock units are subject to forfeiture to the Issuer if underlying vesting conditions are not met.